1-amino-N-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6,7,8,9-tetrahydrothieno[2,3-c]cinnoline-2-carboxamide
C20H20N4O2S — CID 122691461
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-amino-N-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6,7,8,9-tetrahydrothieno[2,3-c]cinnoline-2-carboxamide
1-amino-N-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6,7,8,9-tetrahydrothieno[2,3-c]cinnoline-2-carboxamide (PubChem CID 122691461) has the molecular formula C20H20N4O2S and a molecular weight of 380.47 g/mol. Its IUPAC name is 1-amino-N-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6,7,8,9-tetrahydrothieno[2,3-c]cinnoline-2-carboxamide.
Molecular Properties
| Compound Name | 1-amino-N-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6,7,8,9-tetrahydrothieno[2,3-c]cinnoline-2-carboxamide |
|---|---|
| PubChem CID | 122691461 |
| Molecular Formula | C20H20N4O2S |
| Molecular Weight | 380.47 g/mol |
| Exact Mass | 380.13 |
| IUPAC Name | 1-amino-N-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6,7,8,9-tetrahydrothieno[2,3-c]cinnoline-2-carboxamide |
| SMILES | Nc1c(C(=O)NCc2ccc3c(c2)CCO3)sc2nnc3c(c12)CCCC3 |
| InChI | InChI=1S/C20H20N4O2S/c21-17-16-13-3-1-2-4-14(13)23-24-20(16)27-18(17)19(25)22-10-11-5-6-15-12(9-11)7-8-26-15/h5-6,9H,1-4,7-8,10,21H2,(H,22,25) |
| InChIKey | WPDJPFXBPNAEML-UHFFFAOYSA-N |
| XLogP | 3.02 |
| TPSA | 90.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 380.47 |
| LogP ≤ 5 | 3.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122691461 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.